Ph.D. Student
alba.escalera@icahn.mssm.edu

Notable Publications

Aydillo T, Escalera A, et al., (2020) Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Reports Medicine 1(8):100130.

Nogales A, Aydillo T, Ávila-Pérez G, Escalera A et al., (2019) Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo. Frontiers in Microbiology. 10:2862.

Aydillo T, Rombauts A,  Stadlbauer D, Aslam S, Abelenda-Alonso G,  Escalera A, et al., (2021)  Antibody Immunological Imprinting on COVID-19 Patients. medRxiv. doi: https://doi.org/10.1101/2020.10.14.20212662.

Ho JSY, Mok BW, Campisi L, Jordan T, Yildiz S, Parameswaran S, Wayman JA, Gaudreault NN, Meekins DA, Indran SV, Morozov I, Trujillo JD, Fstkchyan YS, Rathnasinghe R, Zhu Z, Zheng S, Zhao N, White K, Ray-Jones H, Malysheva V, Thiecke MJ, Lau SY, Liu H, Zhang AJ, Lee AC, Liu WC, Jangra S, Escalera A et al., (2021) TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell. 30:S0092-8674(21)00382-2.